Health

A federal vaccine advisory panel voted in December 2025 to move away from a universal hepatitis B birth dose, shifting the decision toward individual parents and clinicians.

An early and intense 2025-26 flu season, driven by a fast-spreading H3N2 variant, is pushing hospitals to capacity in several countries.

Canada lost its measles elimination status in November 2025, a setback that also removes the Americas' region-wide measles-free designation.

Artificial intelligence diagnostic tools are transforming patient care worldwide, with hospitals reporting faster, more accurate disease detection across multiple specialties.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment worldwide, with new approvals and research expanding their medical applications.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment, with new data confirming cardiovascular and kidney benefits.

GLP-1 receptor agonists like semaglutide and tirzepatide continue to transform obesity treatment, cardiovascular care, and healthcare systems worldwide.

A closer look at the ingredients, additives, and ultra-processing in a bag of Cheetos, and what the science actually says about frequent consumption of foods like this.

GLP-1 receptor agonists like semaglutide continue transforming obesity treatment worldwide, with expanded access, new indications, and mounting research reshaping healthcare systems.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment worldwide, with expanding approvals and growing evidence of broader health benefits.

Semaglutide and tirzepatide continue to transform obesity treatment worldwide, with new research expanding their benefits beyond weight loss.

GLP-1 receptor agonists like semaglutide and tirzepatide continue transforming obesity treatment worldwide, with expanding approvals and growing access debates.

GLP-1 receptor agonists like semaglutide and tirzepatide continue to dominate health headlines as new data confirms cardiovascular and metabolic benefits beyond weight loss.

Hantavirus broke into Google's global top searches in 2026 after a cruise-ship outbreak. Here are the facts from the CDC and WHO.

Medications like semaglutide and tirzepatide continue to transform obesity treatment worldwide, with expanding approvals and growing evidence of cardiovascular benefits.